Nci 10013-A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel, with or without atezolizumab in triple negative breast cancer (TNBC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Ademuyiwa, FO; Gao, F; Chen, I; Northfelt, DW; Wesolowski, R; Arora, M; Brufsky, A; Dees, C; Santa-Maria, CA; Connolly, RM; Force, J; Moreno-Aspitia, A; Larson, S; Sharon, E; Gillanders, W

Published Date

  • February 2021

Published In

Volume / Issue

  • 81 / 4

Electronic International Standard Serial Number (EISSN)

  • 1538-7445

International Standard Serial Number (ISSN)

  • 0008-5472